In a filing, Hims & Hers Health Inc revealed its Chief Operating Officer Baird Melissa unloaded Company’s shares for reported $0.17 million on Apr 08 ’24. In the deal valued at $14.74 per share,11,751 shares were sold. As a result of this transaction, Baird Melissa now holds 538,932 shares worth roughly $7.12 million.
Then, Baird Melissa sold 11,751 shares, generating $171,372 in total proceeds. Upon selling the shares at $14.58, the Chief Operating Officer now owns 538,932 shares.
Before that, Dudum Andrew sold 188,888 shares. Hims & Hers Health Inc shares valued at $2,828,075 were divested by the Chief Executive Officer at a price of $14.97 per share. As a result of the transaction, Dudum Andrew now holds 0 shares, worth roughly $0.0.
Canaccord Genuity initiated its Hims & Hers Health Inc [HIMS] rating to a Buy in a research note published on April 10, 2024; the price target was $20. A number of analysts have revised their coverage, including Imperial Capital’s analysts, who increased its forecast for the stock in late February from “an In-line” to “an Outperform”. Leerink Partners began covering HIMS with “Market perform” recommendation on February 26, 2024. Imperial Capital started covering the stock on December 07, 2023. It rated HIMS as “an In-line”.
Price Performance Review of HIMS
On Monday, Hims & Hers Health Inc [NYSE:HIMS] saw its stock fall -5.30% to $13.22. Over the last five days, the stock has lost -11.16%. Hims & Hers Health Inc shares have risen nearly 48.54% since the year began. Nevertheless, the stocks have risen 31.54% over the past one year. While a 52-week high of $17.16 was reached on 03/25/24, a 52-week low of $5.65 was recorded on 01/05/24. SMA at 50 days reached $13.14, while 200 days put it at $9.01. A total of 5.28 million shares were traded, compared to the trading of 2.97 million shares in the previous session.
Levels Of Support And Resistance For HIMS Stock
The 24-hour chart illustrates a support level at 12.92, which if violated will result in even more drops to 12.62. On the upside, there is a resistance level at 13.77. A further resistance level may holdings at 14.32. The Relative Strength Index (RSI) on the 14-day chart is 38.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.94, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.43%. Stochastics %K at 6.90% indicates the stock is a buying.
The most recent change occurred on July 28, 2023 when TD Cowen began covering the stock and recommended ‘”an Outperform”‘ rating along with a $11 price target.
